![FDA Update on Draft Guidance for Digital Health Technologies in Clinical Trials](https://d38uvx7mib76ry.cloudfront.net/public/images/oyAiYw7FQfXftPngvMGLK89GnpLIaHelkw8xO7zG.png)
Summary:
In this podcast, you will hear three FDA representatives provide updates on the draft guidance issued December 2021 that provides recommendations for clinical trial sponsors, investigators, sites on using DHTs to collect data remotely from clinical trial participants.
They spoke specifically on guidance updates; the requirements to test all of these digital health technologies; efforts the agency is putting in place to harmonize the requirements across the board; guidance to the industry for harmonization; and FDA update on approval of additional clinical measures. This conversation was moderated by Dr Lauren Oliva, Biogen, at the 2022 Mobile Tech in Clinical Trials conference.
To learn more about the Mobile Tech in Clinical Trials conference, please visit mobileinclinicaltrials.com
SpeakersRelated Podcasts
View All![Preferences in Decentralization and Digitalization of Pediatric Clinical Trials: Case Study](https://d38uvx7mib76ry.cloudfront.net/public/images/KRCjqX07kLJ0SL4dvkzKWHu2k4zTF6KJRldzVB8V.png)
Preferences in Decentralization and Digitalization of Pediatric Clinical Trials: Case Study
![Optimizing the Integration of Mobile, Patient-Facing Technologies in Clinical Trials for Accessibility and Flexibility](https://d38uvx7mib76ry.cloudfront.net/public/images/QvF6WsV1McmJEIl7xaQnVJszPxkclRJpeMahwZtQ.png)
Optimizing the Integration of Mobile, Patient-Facing Technologies in Clinical Trials for Accessibility and Flexibility
![Delivering Exceptional Clinical Trial Experiences for Patients](https://d38uvx7mib76ry.cloudfront.net/public/images/T3xgX7ADqfhMees6nwfMIA39eY0LVFEDaBMa04sd.png)
Delivering Exceptional Clinical Trial Experiences for Patients
![Measuring the Value of DCTs and Hybrid Models for Ultimate Trial Success](https://d38uvx7mib76ry.cloudfront.net/public/images/NpWjk0KiWqAvOIgFpl1XXajvZj7XbHjyVuXzwZNv.png)